Methylglyoxal and methylglyoxal-arginine adducts do not directly inhibit endothelial nitric oxide synthase

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 231-234

  Brouwers, Olaf ^a   Teerlink, Tom ^b   Van Bezu, Jan ^b   Barto, Rob ^b   Stehouwer, Coen D A ^a   Schalkwijk, Casper G ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AGEs; Asymmetric dimethylarginine; eNOS activity; Glycation; Methylglyoxal

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; ARGININE DERIVATIVE; CITRULLINE; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMIDAZOLE DERIVATIVE; METHYLGLYOXAL;

CONFERENCE PAPER; DIABETIC ANGIOPATHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 42549106767     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.017     Document Type: Conference Paper

References (17)

1. 1 Bucala, R., K.J. Tracey & A. Cerami. 1991. Advanced glycosylation products quench nitric oxide and mediate defective endothelium‐dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87: 432–438.
2. 2 Tan, K.C. et al. 2002. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25: 1055–1059.
3. 3 Shinohara, M. et al. 1998. Overexpression of glyoxalase‐I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia‐induced increases in macromolecular endocytosis. J. Clin. Invest. 101: 1142–1147.
4. 4 Schalkwijk, C.G. et al. 2006. Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cells. FEBS Lett. 580: 1565 ‐ 1570.
5. 5 Ahmed, N. et al. 2002. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6‐aminoquinolyl‐N‐hydroxysuccinimidyl‐carbamate and application to Nepsilon‐carboxymethyl‐lysine‐ and Nepsilon‐(1‐carboxyethyl)lysine‐modified albumin. Biochem. J. 364: 1–14.
6. 6 Huang, P.L. et al. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239–242.
7. 7 Vallance, P. et al. 1992. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572–575.
8. 8 Havenga, M.J. et al. 2001. Simultaneous detection of NOS‐3 protein expression and nitric oxide production using a flow cytometer. Anal. Biochem. 290: 283–291.
9. 9 Oya, T. et al. 1999. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal‐arginine adducts. J. Biol. Chem. 274: 18492–18502.
10. 10 Thornalley, P.J. et al. 2003. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 375: 581–592.
11. 11 Lapolla, A. et al. 2003. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 41: 1166–1173.
12. 12 Teerlink, T. 2007. HPLC analysis of ADMA and other methylated L‐arginine analogs in biological fluids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851: 21–29.
13. 13 Horowitz, J.D. & T. Heresztyn. 2007. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 851: 42–50.
14. 14 Tsikas, D. et al. 2000. Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox. FEBS Lett. 478: 1–3.
15. 15 Noyman, I. et al. 2002. Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide 7: 187–193.
16. 16 Xiong, Y. et al. 2003. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin‐induced diabetes. J. Cardiovasc. Pharmacol. 42: 191–196.
17. 17 Yin, Q.F. & Y. Xiong. 2005. Pravastatin restores DDAH activity and endothelium‐dependent relaxation of rat aorta after exposure to glycated protein. J. Cardiovasc. Pharmacol. 45: 525–532.